Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

SIMPLE SUMMARY: Esophageal squamous cell carcinoma (ESCC) represents roughly 85–90% of all esophageal carcinoma patients in China. Immunotherapy is used to treat an increasing number of ESCC patients in clinical practice. This study aims to understand the molecular heterogeneity and the tumor immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yulong, Gao, Qiqi, Su, Xingyun, Xiao, Cheng, Yu, Bo, Huang, Shenglin, Sun, Yifeng, Wu, Sheng, Wo, Yixin, Xu, Qinghua, Xu, Nong, Yu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599230/
https://www.ncbi.nlm.nih.gov/pubmed/36291754
http://dx.doi.org/10.3390/cancers14204970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599230/
https://www.ncbi.nlm.nih.gov/pubmed/36291754
http://dx.doi.org/10.3390/cancers14204970

Ejemplares similares